Charles River Laboratories News, Charles River Laboratories Quote, CRL Quote

Charles River Laboratories (NY:CRL) Delayed: 226.01 -13.42 (5.6%)

Prev. Close

$239.43

Open

$237.31

52 Wk High

$89.18

52 Wk Low

$65.70

Day High

$237.31

Day Low

$226.01

P/E

105.12

EPS

$2.15

Volume

235,599

Friends, Peers and Foes (?): DIS, STEM, VIRT, CUTR, TDS (more...)

Apr 24, 2024 07:30 AM Form DEFA14A CHARLES RIVER LABORATORI
Apr 22, 2024 08:00 AM Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
Apr 16, 2024 08:03 AM Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Apr 12, 2024 08:00 AM Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
Apr 11, 2024 08:00 AM Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Apr 9, 2024 08:08 AM Charles River Laboratories (CRL) Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Apr 9, 2024 08:00 AM Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Apr 4, 2024 08:00 AM Charles River to Perform Plasmid Production for Ship of Theseus
Apr 3, 2024 06:37 AM Charles River Labs (CRL) PT Raised to $282 at Baird
Apr 2, 2024 09:00 PM CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Entities mentioned with CRL